Li L, Chen J, Wang J, Cai D (2015) Prevalence and risk factors of diabetic peripheral neuropathy in type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China. Prim Care Diabetes 9(3):191–195. https://doi.org/10.1016/j.pcd.2014.07.006

Article  PubMed  Google Scholar 

Zhao Z, Ji L, Zheng L et al (2016) Effectiveness of clinical alternatives to nerve conduction studies for screening for diabetic distal symmetrical polyneuropathy: a multi-center study. Diabetes Res Clin Pract 115:150–156. https://doi.org/10.1016/j.diabres.2016.01.002

Article  PubMed  Google Scholar 

Callaghan BC, Gao L, Li Y et al (2018) Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Ann Clin Transl Neurol 5(4):397–405. https://doi.org/10.1002/acn3.531

Article  PubMed  PubMed Central  Google Scholar 

Volmer-Thole M, Lobmann R (2016) Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci 17(6):917. https://doi.org/10.3390/ijms17060917

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peterson JM, Wei Z, Wong GW (2010) C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 285(51):39691–39701. https://doi.org/10.1074/jbc.M110.180695

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Jiang L, Yang M, Wu YW, Sun JZ, Sun SX (2014) CTRP3 improves the insulin sensitivity of 3T3-L1 adipocytes by inhibiting inflammation and ameliorating insulin signalling transduction. Endokrynol Pol 65(4):252–258. https://doi.org/10.5603/EP.2014.0034

Article  PubMed  Google Scholar 

Lin J, Liu Q, Zhang H, Huang X, Zhang R, Chen S, Wang X, Yu B, Hou J (2017) C1q/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPARγ and TLR4-mediated pathways. Oncotarget 8(47):82541–82557. https://doi.org/10.18632/oncotarget.19657

Article  PubMed  PubMed Central  Google Scholar 

Zhang B, Zhang P, Tan Y et al (2019) C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. Cell Death Dis 10(7):520. https://doi.org/10.1038/s41419-019-1749-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang S, Zhou Y, Yang B, Li L, Yu S, Chen Y, Zhu J, Zhao Y (2016) C1q/Tumor necrosis factor-related Protein-3 attenuates Brain Injury after Intracerebral Hemorrhage via AMPK-Dependent Pathway in Rat. Front Cell Neurosci 10:237. https://doi.org/10.3389/fncel.2016.00237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Wright GL, Peterson JM (2017) C1q/TNF-Related protein 3 (CTRP3) function and regulation. Compr Physiol 7(3):863–878. https://doi.org/10.1002/cphy.c160044

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Zhang B, Cheng Y, Xu J (2018) Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Cytokine 106:131–135. https://doi.org/10.1016/j.cyto.2017.10.023

Article  CAS  PubMed  Google Scholar 

American Diabetes Association (2020) 2. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes-2020. Diabetes Care 43(Suppl 1):S14–S31. https://doi.org/10.2337/dc20-S002

Article  Google Scholar 

Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17(11):1281–1289. https://doi.org/10.2337/diacare.17.11.1281

Article  CAS  PubMed  Google Scholar 

Gibbons CH, Freeman R, Veves A (2010) Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care 33(12):2629–2634. https://doi.org/10.2337/dc10-0763

Article  PubMed  PubMed Central  Google Scholar 

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, Toronto Diabetic Neuropathy Expert Group (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10):2285–2293. https://doi.org/10.2337/dc10-1303

Article  PubMed  PubMed Central  Google Scholar 

Song Y, Zhang Y, Wan Z, Pan J, Gao F, Li F, Zhou J, Chen J (2022) CTRP3 alleviates myocardial ischemia/reperfusion injury in mice through activating LAMP1/JIP2/JNK pathway. Int Immunopharmacol 107:108681. https://doi.org/10.1016/j.intimp.2022.108681

Article  CAS  PubMed  Google Scholar 

Liu D, Cui X, Lu R, Hu H, Gu G (2022) CTRP3 is a coronary artery calcification biomarker and protects against vascular calcification by inhibiting β-catenin nuclear translocation to prevent vascular smooth muscle cell osteogenic differentiation. J Cardiol 79(4):551–558. https://doi.org/10.1016/j.jjcc.2021.10.018

Article  PubMed  Google Scholar 

Yan Z, Wang C, Meng Z et al (2022) C1q/TNF-Related protein 3 prevents Diabetic Retinopathy via AMPK-Dependent stabilization of blood-retinal barrier tight junctions. Cells 11(5):779. https://doi.org/10.3390/cells11050779

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moradi N, Fadaei R, Khamseh ME, Nobakht A, Rezaei MJ, Aliakbary F, Vatannejad A, Hosseini J (2019) Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLoS ONE 14(4):e0215617. https://doi.org/10.1371/journal.pone.0215617

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javed S, Hayat T, Menon L, Alam U, Malik RA (2020) Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late. Diabet Med 37(4):573–579. https://doi.org/10.1111/dme.14194

Article  CAS  PubMed  Google Scholar 

Wolf RM, Lei X, Yang ZC, Nyandjo M, Tan SY, Wong GW (2016) CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice. Am J Physiol Endocrinol Metab 310(5):E332–E345. https://doi.org/10.1152/ajpendo.00248.2015

Article  PubMed  Google Scholar 

Deng W, Li C, Zhang Y, Zhao J, Yang M, Tian M, Li L, Zheng Y, Chen B, Yang G (2015) Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance. Diabetol Metab Syndr 7:33. https://doi.org/10.1186/s13098-015-0029-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Wang F, Chu Z, Shi X, Sun L, Lv H, Zhou W, Shen J, Chen L, Hou M (2019) Serum CTRP3 levels in obese children: a potential protective adipokine of obesity, insulin sensitivity and pancreatic β cell function. Diabetes Metab Syndr Obes 12:1923–1930. https://doi.org/10.2147/DMSO.S222066

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandireddy R, Yerra VG, Areti A, Komirishetty P, Kumar A (2014) Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol 2014:674987. https://doi.org/10.1155/2014/674987

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, He J (2019) CTRP3 inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. Artif Cells Nanomed Biotechnol 47(1):3758–3764. https://doi.org/10.1080/21691401.2019.1666864

Article  CAS  PubMed  Google Scholar 

Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, Wu QQ, Liao HH, Ni J, Tang QZ (2017) CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia 60(6):1126–1137. https://doi.org/10.1007/s00125-017-4232-4

Article  CAS  PubMed  Google Scholar 

Zhang J, Xu J, Lin X, Tang F, Tan L (2021) CTRP3 ameliorates fruct